Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Jan;27(1):59-68.
doi: 10.1002/pds.4349. Epub 2017 Nov 17.

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

Matthew F Daley  1   2 , Christina L Clarke  1 , Jason M Glanz  1 , Stanley Xu  1 , Simon J Hambidge  1   2   3 , James G Donahue  4 , James D Nordin  5 , Nicola P Klein  6 , Steven J Jacobsen  7 , Allison L Naleway  8 , Michael L Jackson  9 , Grace Lee  10 , Jonathan Duffy  11 , Eric Weintraub  11
Affiliations
Multicenter Study

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study

Matthew F Daley et al. Pharmacoepidemiol Drug Saf. 2018 Jan.

Abstract

Purpose: To evaluate the safety of live attenuated influenza vaccine (LAIV) in children 2 through 17 years of age.

Methods: The study was conducted in 6 large integrated health care organizations participating in the Vaccine Safety Datalink (VSD). Trivalent LAIV safety was assessed in children who received LAIV between September 1, 2003 and March 31, 2013. Eighteen pre-specified adverse event groups were studied, including allergic, autoimmune, neurologic, respiratory, and infectious conditions. Incident rate ratios (IRRs) were calculated for each adverse event, using self-controlled case series analyses. For adverse events with a statistically significant increase in risk, or an IRR > 2.0 regardless of statistical significance, manual medical record review was performed to confirm case status.

Results: During the study period, 396 173 children received 590 018 doses of LAIV. For 13 adverse event groups, there was no significant increased risk of adverse events following LAIV. Five adverse event groups (anaphylaxis, syncope, Stevens-Johnson syndrome, adverse effect of drug, and respiratory failure) met criteria for manual medical record review. After review to confirm cases, 2 adverse event groups remained significantly associated with LAIV: anaphylaxis and syncope. One confirmed case of anaphylaxis was observed following LAIV, a rate of 1.7 per million LAIV doses. Five confirmed cases of syncope were observed, a rate of 8.5 per million doses.

Conclusions: In a study of trivalent LAIV safety in a large cohort of children, few serious adverse events were detected. Anaphylaxis and syncope occurred following LAIV, although rarely. These data provide reassurance regarding continued LAIV use.

Keywords: anaphylaxis; child; live attenuated influenza vaccine; pharmacoepidemiology; syncope; vaccine safety.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None declared.

Similar articles

See all similar articles

Cited by

References

    1. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016;65:1–54. - PubMed
    1. Caspard H, Gaglani M, Clipper L, et al. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2‐17 years of age in 2013‐2014 in the United States. Vaccine 2016;34:77–82. - PubMed
    1. Chung JR, Flannery B, Thompson MG, et al. Seasonal effectiveness of live attenuated and inactivated influenza vaccine. Pediatrics 2016;137:e20153279. - PMC - PubMed
    1. Gaglani M, Pruszynski J, Murthy K, et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013‐2014 in the United States. J Infect Dis 2016;213:1546–1556. - PMC - PubMed
    1. Pebody R, Warburton F, Ellis J, et al. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory‐confirmed influenza in primary care in the United Kingdom: 2015/16 end‐of‐sea-son results. Euro Surveill 2016;21. - PMC - PubMed

Publication types

MeSH terms